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Abstract
Background: Antiretroviral therapy (ART) may influence the biological, social and behavioral determinants of pregnancy in
HIV-infected women. However, there are limited longitudinal data on the reproductive intentions and outcomes among
women on ART in Africa.
Methodology /Principal Findings: Using a prospective cohort design, we analyzed trends in desire for children and
predictors of pregnancy among a cohort of 733 HIV-infected women in rural Uganda who initiated ART between May 2003
and May 2004 and were followed up in their homes until June 2006. Women answered in-depth social and behavioral
questionnaires administered every quarter in year 1 after initiating ART, and every 6 to 12 months thereafter. Use of family
planning methods was assessed at 18 and 24 months after starting ART. We tested for non-constant pregnancy incidence by
using a shape parameter test from the Weibull distribution. We modeled repeated measurements of all variables related to
the women’s desire for children over time using a generalized estimating equation (GEE) extension to the logistic regression
model. Risk factors for pregnancy were examined using Cox proportional hazards model. 711 women eligible for the study
were followed-up for a median time of 2.4 years after starting ART. During this time, less than 7% of women reported
wanting more children at any time point yet 120 (16.9%) women experienced 140 pregnancies and pregnancy incidence
increased from 3.46 per 100 women-years (WY) in the first quarter to 9.5 per 100 WY at 24 months (p,0.0001). This was
paralleled by an increase in the proportion of women reporting sexual activity in the past 3 months, from 24.4% at baseline
to 32.5% over 24 months of follow-up (p = 0.001). Only 14% of women used permanent or semi-permanent family planning
methods by their second year on ART. In the multivariate model, younger age (HR= 2.71 per 10-year decrease, 95% CI: 2.95–
3.78), having a BMI.18.5 (HR= 1.09, CI: 1.01–1.18) and not having used condoms consistently in the last 3 months
(HR= 1.79, CI: 1.02–3.13) were independently associated with pregnancy.
Conclusion/Significance:Women on ART and their partners should be consistently counseled on the effects of ART in restoring
fertility, and offered regularly free and comprehensive family planning services as part of their standard package of care.
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Introduction
Antiretroviral therapy (ART) restores health and fertility in
people living with HIV and drastically reduces mother-to-child
transmission (MTCT) of HIV [1,2,3]. As major efforts are under
way to expand access to this life-saving treatment in sub-Saharan
Africa [4,5], thousands of men and women on ART are resuming a
socially productive and sexually active lives involving protected and
unprotected sex with or without a desire for children [2,6,7,8].
Numerous behavioral and contextual factors interact in a complex
way to determine intended and unintended reproductive outcomes
among women living with HIV. Age, marital, educational, and socio-
economic status, cultural and religious beliefs, sexual behavior as well
as family size and losses, and access to family planning services are
documented predictors of pregnancy [9,10,11,12,13]. In sub-Saharan
Africa where HIV prevalence is highest, these factors may be
considerably influenced by the traditional roles of women, the socio-
cultural importance of motherhood, and a woman’s partner’s desire
for children independent of her own [14,15,16,17]. The added risk of
MTCT of HIV through breastfeeding [18] and a reduced capacity
for timely diagnosis and treatment of infants infected with HIV [19]
compounds the complexity of the choices that couples or women
living with HIV must make in relation to childbearing.
ART adds a new dimension to this situation, challenging people
living with HIV/AIDS (PLHA), their partners and their care
providers to address the impact of ART on their fertility, sexual
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behavior and reproductive decisions. Recent cross-sectional
surveys and qualitative studies have shown that women on ART
in sub-Saharan resume their love and sexual life once their health
is restored and want to have children [7,8,20]. This study
examined the reproductive intentions and outcomes over 2 years
of follow-up among 733 HIV-infected women on ART enrolled in
a prospective cohort study in rural Uganda.
Methods
Objectives
The specific objectives of this study were 1) to compare the
baseline characteristics of HIV-infected women who did or did not
became pregnant following their initiation of ART, 2) to analyze
trends in pregnancy incidence, desire for children and sexual
activity over time among these women following ART initiation,
3) to describe the rate of unmet need for family planning and the
rate of contraceptive use among these women after 2 years of
follow-up, and 4) to assess independent risk factors for pregnancy
over 2 years of follow-up post ART initiation.
Participants
Women included in this analysis were part of the Home-Based
AIDS Care (HBAC) study, a randomized trial of three different
ART monitoring strategies involving 1,092 HIV-infected men and
women in Tororo and Busia districts in rural Eastern Uganda [15]
(Figure 1). HBAC study participants were recruited among clients
of the Tororo branch of The AIDS Support Organization
(TASO), an indigenous non-governmental organization providing
medical and psycho-social care and support for PLHA. Starting in
March 2003, TASO clients $18 years-old were screened for ART
eligibility and were offered first-line ART if they had a CD4 cell
count ,250 cells/mL or were in WHO disease stage 3 or 4. All
households participating in the study received insecticide-treated
bed nets to reduce malaria incidence and a water vessel with a
supply of chlorine for diarrheal disease prevention. All household
members were offered home-based HIV counseling and testing;
99% of them accepted and those diagnosed with HIV were offered
couple counseling, were provided with free care and treatment,
and were offered enrollment in HBAC [21]. Among HBAC
participants, 97% of sexually active women and 98% of sexually
active men had disclosed their HIV sero-status to a median of 15
people at baseline, including their sexual partner (Nakayiwa S. et
al., unpublished data), reflecting TASO’s long-standing ‘positive
living’ philosophy which includes empowering PLHA to disclose
their HIV sero-status [22].
Enrolment and follow-up procedures – HBAC study
As part of the enrollment into HBAC, participants underwent
physical examinations and answered in-depth questionnaires to
evaluate their social, behavioral, and economic baseline charac-
teristics as well as clinical history. Study participants were
counseled at enrolment about the potential effects of ART on
improving health status, restoring fertility and sexual activity, and
were offered referral to the district hospital family planning (FP)
clinic that was adjacent to the study clinic if interested in using any
Figure 1. HBAC pregnancy sub-study enrolment and follow-up flow chart.
doi:10.1371/journal.pone.0004149.g001
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FP method other than condoms. The hospital FP clinic provided
standard FP counseling and free FP services including any number
of clinic visits and contraceptives supplied by the Ministry of
Health including combined oral and progesterone-only pills,
hormonal injectables and implants, intra-uterine devices, tubal
ligation, and condoms. Condoms were also available for free from
all HBAC clinicians, counselors and home visitors, both at the
study clinic and during home visits.
After enrollment, HBAC participants were visited in their
homes on a weekly basis by trained lay workers who delivered
drugs, conducted pill counts and monitored participants’ clinical
status using standardized checklists. No routine clinic visits were
scheduled but participants could come to the clinic or hospital
when experiencing acute symptoms or showing signs of potential
drug toxicity or disease progression. There were no clinic visits fees
or any other charge associated with the care provided by HBAC.
Home visitors weighed participants and asked women for the date
of their last menstrual period on a monthly basis. Women were
tested for pregnancy if they had missed their periods for more than
4 weeks. Home visitors also drew blood from participants on a
quarterly basis for measurement of CD4 count and viral load.
HBAC counselors visited participants quarterly in their homes to
provide systematic confidential counseling for psycho-social
support, treatment adherence and prevention of sexual transmis-
sion of HIV including safer sex and family planning counseling
and condoms.
Counseling sessions were carried out in the participants’ native
language and lasted on average 30 minutes. Counselors also
administered in-depth questionnaires related to social and
behavioral factors including sexual practices at baseline and
quarterly in the first year of follow-up, bi-annually in year 2, and
annually in year 3, except for a module on HIV transmission
knowledge and desire for children which was administered
annually as of year 2. These interviews lasted on average 1 hour
and were also carried out in the participants’ own home and own
language. Women’s partners were not interviewed unless they
were an HBAC index client. In this study, the partners’ desire for
children was reported through the women.
The team of home visitors consisted in 30 lay workers trained by
HBAC investigators in basic counseling, clinical and adherence
monitoring, and referral. The team of counselors consisted in 12
certified and experienced professional counselors trained by
HBAC investigators in research methods, behavioral and
counseling theory, and family planning in relation to HIV/AIDS.
Each home visitor and counselor was assigned to a given
household for the entire duration of the study in order to increase
the trust of the participants and enhance the validity of the
information collected throughout the study. The frequency of
home visits and the counseling messages remained the same over
the course of the study. The original HBAC study duration was 36
months (median cohort follow-up) but this cohort had taken part
in two preceding home-based studies [23,24], thus most counselors
and home visitors had been with their assigned household for over
a year at the time the HBAC study started.
Enrolment and follow-up procedures - pregnancy sub-
study
All female HBAC participants 18–49 years old who initiated
ART between March 2003 and May 2004 were included in the
pregnancy sub-study. Pregnancies occurring during follow-up
were identified through clinic and home visits and were confirmed
by one or more of the following criteria: a positive human
chorionic gonadotropin test, a positive obstetrical examination, the
presence of fetal heart beat, a history of abortion, or the delivery of
a baby.
Pregnant women were educated about giving single-dose
nevirapine prophylaxis to their newborn babies for the prevention
of MTCT of HIV and were counseled to exclusively breastfeed for
3 to 6 months followed by rapid weaning as per Uganda’s national
PMTCT guidelines at the time [25]. Pregnancy outcomes were
recorded by field and clinical staff. Post-conception counseling did
not provide or refer clients for pregnancy termination services as
voluntary abortion is illegal in Uganda. However, women who
pursued termination on their own were asked about their
experiences and were treated for any complications.
Ethics
All participants provided written consent to participate in the
HBAC study in one of six local languages. The HBAC study and
the pregnancy sub-study were approved by the Science and Ethics
Committee of the Uganda Virus Research Institute, the Uganda
National Council of Science and Technology, and the institutional
review boards of the Centers for Disease Control and Prevention
(CDC), Atlanta, Georgia, USA, and of the University of
California, San Francisco, California, USA.
Statistical methods
Women with a confirmed pregnancy and whose last menstrual
period occurred at least one month after the date of ART
initiation were considered to have become pregnant while on
ART. Women who were pregnant at the time of starting ART
were enrolled 1 month after the end of their pregnancy.
Assessment of the last normal menstrual period date was based
on self-report, assessment of fundus height, or back dating from
actual date of delivery of a live baby. Women who discontinued
ART for more than 3 continuous months were excluded from the
analysis during the time of treatment discontinuation. Women
who did not become pregnant were censored at the date of
discharge or on June 30th 2006. Women who became pregnant
were censored at the estimated date of conception. Conception
date was estimated at 15 days after the date of the last reported or
estimated normal menstrual period. Based on these criteria, 711 of
733 women enrolled in the HBAC trial were eligible for this study
(Figure 1). Three of these women were missing baseline data and
thus were excluded from the baseline and multivariate analyses.
We compared the baseline characteristics of women who did or
did not became pregnant using the Wilcoxon rank sum test for
continuous variables and the Chi-squared test for categorical
variables. We analyzed trends in pregnancy incidence and desire
for children over time. We tested for non-constant incidence of
pregnancy by using a test for the shape parameter from the
Weibull distribution [26]. We modeled repeated measurements of
all variables related to the women’s desire for children over time
using a generalized estimating equation extension (GEE) to the
logistic regression model [27]. The p-values were derived from a
chi-square test of a linear trend arising out of the GEE model. We
examined the issue of linearity by performing a test for departure
from linear trend which was not significant. We also described
family planning practices and the unmet need for family planning
services in the second year of follow-up.
Risk factors for pregnancy were examined using the Cox
proportional hazards model [28]. We assessed the unadjusted
effects of potential risk factors for the first incident pregnancy using
the log rank test [29]. Subsequent pregnancies were not included
in the bi- and multivariate analyses. Adjusted predictor effects
were summarized using hazard ratios (HR) from the multivariable
models. Most predictor variables were assessed at multiple time
Pregnancy & ART in Uganda
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points during follow-up. We treated these variables as time-
dependent covariates [30] unless otherwise specified. At a given
time point, the value of the predictor variable was determined by
the most recent prior measurement. All p-values are two-sided. All
analyses were conducted in Stata version 9.0 (Stata Corporation,
College Station, Texas, USA).
Results
Enrolment and baseline characteristics (Figure 1 &
Table 1)
Women enrolment is summarized in Figure 1 and enrolled
women’s characteristics are described in Table 1. 711 women were
enrolled and followed up for a median of 2.44 years (interquartile
range (IQR): 2.32–2.62); of these, 11 (1.6%) were lost to follow-up,
5 (0.6%) discontinued ART for .3 months, and 36 (5.1%) died.
Among 708 women with baseline data, median age was 37 years
(IQR 31–41), 28% (194/702) of all women were married or co-
habiting with their partner, 57% (398/702) were widowed, 24%
(169/702) had no formal education, and 97% (661/684) had one
or more living children (median 4 children (IQR: 1–5). Twenty-
four percent (169/694) of women reported being sexually active at
baseline, 2% (3/168) of whom reported having more than 1
current sexual partner, and 56% (95/169) reported having always
used a condom with their sexual partner in the last 3 months.
Forty-five percent (315/697) of the women reported ever having
been physically abused by their partner (Table 1).
At baseline, women who became pregnant after starting ART
were younger than their non-pregnant counterparts (median age
32 vs. 38 years; p,0.0001), more likely to be married and/or co-
habiting with their partner (40% vs 25%; p= 0.002), to have been
pregnant in the last 12 months (13% vs 3%; p,0.0001), and to
have experienced the death of a child (74% vs 60%; p= 0.004), but
less likely to have experienced the death of a spouse or partner
(54% vs 66%; p= 0.014). Pregnancy was not associated with the
women’s allocation to the various ART monitoring arms of the
HBAC trial (Table 1).
Desire for children and incidence of pregnancy (Figure 2)
Desire for children increased significantly over follow-up for
both the women (p,0.004) and their partners (p = 0.0001) but
remained under 7% for the women and under 26% for their
partners throughout follow-up. The proportion of women
reporting sexual activity within 3 months of the interview also
increased significantly over time (p= 0.0001), which was reflected
by an increased frequency of sex in the past month or the past
week (both p-values = 0.001).
A total of 120 (17%) women experienced 140 pregnancies after
initiation of ART. Median time to first incident pregnancy was
12.4 months (IQR 7.9–18.0) after starting ART. Four of the140
incident pregnancies produced a set of twins and 38 (26%) did not
result in a live birth; of these, 4 were spontaneous miscarriages, 8
were stillbirths including one of the twins, and 26 were induced
abortions. Overall pregnancy incidence rate was 8.20 per 100
women-years (WY), increasing from 3.5 per 100 WY in the first
quarter post-ART to 11.7 per 100 WY in the fifth quarter of
follow-up, and ranging between 6.1 and 9.5 per 100 WY thereafter
(p,0.0001) (Figure 2).
Family planning (Table 2)
Among sexually active women, 65% (112/173) reported using
condoms 18 months after starting ART and 63% (119/188) at 2
years of follow-up. However, only 14% (24/173) and 13% (25/
188) reported using a semi-permanent (hormonal injection or
implant) or permanent (tubal ligation) contraceptive method at 18
months, and 3.5% (6/173) and 4.3% (8/188) reported using dual
contraception (a hormonal and barrier method in combination)
after 24 months on ART. Among 176 sexually active women not
desiring children at 2 years of follow-up, 33% (59) did not use any
method, 53% (93) used condoms alone, 86% (152) were not using
any semi-permanent or permanent method, and nearly 96% (168)
did not use dual contraception (Table 2).
Determinants of pregnancy (Table 3)
Factors associated with an increased risk of pregnancy included
young age (HR=3.16 per 10 year decrease, CI: 2.30–4.34,
p,0.001), being married or co-habiting with a partner
(HR=2.72, CI: 1.88–3.95, p,0.001), having a body mass index
(BMI)$18.5 near the time of conception (HR=2.5, CI: 1.02–
5.88, p = 0.037), having a higher CD4 cell count near the time of
conception (HR=1.001 per 50 cells increase, CI: 1.000–1.002,
p = 0.045), having experienced the loss of a child during follow-up
(HR=1.63, CI: 1.06–2.50, p = 0.025), and having used condoms
inconsistently with one’s current sexual partner in the last 3
months (HR=1.82, CI: 1.05–3.23, p = 0.033). Factors associated
with a decreased risk of pregnancy included having experienced
the death of a spouse during follow-up (HR=0.19, CI: 0.04–0.88,
p = 0.034), and being in a longer relationship with one’s current
sexual partner (HR=0.97 per year of relationship, CI: 0.94–0.99,
p = 0.023), (Table 3).
In the adjusted model (Table 3), being younger (HR=2.71 per
10-year decrease in age, CI: 1.95–3.78, p,0.001), having a
BMI$18.5 (HR=1.09, CI: 1.01–1.18, p= 0.024) and having
inconsistently used a condom with the most recent sexual partner
in the last 3 months (HR=1.79, CI: 1.02–3.13, p = 0.041)
remained independently associated with pregnancy. Being married
or cohabiting with a partner (HR=1.59, CI: 0.94–2.69, p= 0.08)
had a borderline association with pregnancy. However, time-
updated CD4 counts (HR=1.025; CI: 0.98–1.07, P = 0.26),
having experienced the death of a child (HR=1.94; CI: 0.64–
5.95, p= 0.24) or a spouse (HR=0.49, CI: 0.13–1.83, p= 0.29) or
the length of the sexual relationship with the most recent partner
(HR=0.82; CI: 0.65–1.95, p= 0.31) were no longer independent-
ly associated with pregnancy.
Discussion
In this cohort of women receiving ART in rural Uganda, sexual
activity and incidence of pregnancy significantly increased over
follow-up, yet more than 93% of the women repeatedly expressed
not wanting or not planning to have more children and said the
same was true for more than 75% of their partners. In addition,
over 86% of sexually active women not desiring children were not
using any modern contraception method other than condoms after
2 years on ART and over 95% of them did not use dual
contraception despite having been counseled on family planning at
the time of ART initiation and having been offered referral to the
local family planning clinic. The rates of desire for children that
the women reported for themselves and their partners increased
significantly but remained low throughout follow-up and neither
increase was significantly associated with pregnancy. In multivar-
iate analyses, only young age, having a BMI$18.5 and not using
condoms consistently in the last 3 months were independently
associated with pregnancy.
To our knowledge, these results represent the first of two
longitudinal analyses of fertility intentions and outcomes among
women on ART in sub-Saharan Africa, together with data from
another Ugandan cohort [31]. Our data support observations
Pregnancy & ART in Uganda
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Table 1. Baseline biological, socio-economic, and behavioral characteristics of women on ART (N= 708*).
Socio-economic status Pregnant after ART NOT pregnant after ART p-value
N=117* % or (IQR) N=591 % or (IQR)
Median age (years) 32 (30–36) 38 (32–42) ,0.0001
Median follow-up (years) 2.40 (2.29–2.56) 2.46 (2.33–2.63) 0.10
Education None 28 25% 141 24% 0.58
Primary 65 57% 313 53%
Post-primary 21 18% 134 23%
Religion Christian 110 97% 557 95% 0.52
Moslem 4 3.5% 25 4.3%
Other 0 0% 6 1.0%
Marital Status Single 8 7% 24 4.1% 0.002
Married / co-habiting 46 40% 148 25%
Separated / divorced 13 11% 65 11%
Widowed 48 42% 350 60%
Income Farming 33 29% 183 31% 0.93
Trade 41 35% 184 31%
Dependent 21 18% 101 17%
Wages & others 17 15% 100 18%
None 3 3% 19 3%
Family situation and desire for children
Has biological children 115 99% 568 97% 0.55
Total no. of live children 0 3 2.6% 20 3.5% 0.45
1–2 36 31% 147 26%
3+ 76 66% 402 71%
Total no. of deceased children 0 28 24% 192 34% 0.13
1–2 60 52% 266 47%
3+ 27 24% 109 19%
Experienced death of child ever 86 74% 341 60% 0.004
in last 12 months 8 9.3% 25 7.4% 0.55
Experienced death of spouse/partner ever 63 54% 382 66% 0.014
in last 12 months 9 14% 28 7.3% 0.065
Experienced marriage break-up ever 56 49% 241 42% 0.16
in last 12 months 9 16% 15 6.3% 0.025
Wants more children 5 4.4% 17 2.9% 0.39
Planning to have more children 1 1.0% 9 1.9% 0.47
Partner wants more children ** 13 22% 39 19% 0.63
Clinical status
WHO Staging 1–2 72 62% 329 56% 0.24
3–4 45 38% 262 44%
Body mass index ,18.5 30 26% 138 24% 0.21
18.5–24.9 81 70% 391 68%
$25 4 3.5% 47 8.2%
CD4 count #50 21 18% 100 17% 0.95
.50 to 200 66 56% 333 56%
.200 30 26% 158 27%
Median (IQR) 141 (71–204) 138 (76–204) 0.99
Pregnant at baseline 4 3.8% 11 1.9% 0.27
in last 12 months 15 13% 18 3.1% ,0.0001
Trial arm (ART monitoring): Clinical+CD4+viral load 40 34% 195 33% 0.86
Clinical+CD4 count 43 37% 205 35%
Clinical only 34 29% 191 32%
Pregnancy & ART in Uganda
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from industrialized countries that ART restores fertility in women
living with HIV [2,3]. Moreover they agree with recent reports on
determinants of pregnancy among women on ART in Africa
[31,32]. However they contrast with recent cross-sectional studies
reporting higher rates of desire for children among women and/or
couples on ART in sub-Saharan Africa [7,20]. This may result
from the difference in study design as well as reflect the particular
characteristics of the HBAC cohort.
The contrast between the low rate of self-reported desire for
children and the low rate of contraceptive use by the women in
this cohort raises the question of possible bias due to social
desirability or stigma. While social desirability cannot be totally
ruled out, this low desire for children needs to be considered in the
broader context of this study: 1) The HBAC counselors who
administered the socio-behavioral questionnaires strived to
minimize this bias through establishing a long-term, trustful and
non-judgmental relationship with their clients; 2) Based on
previous findings from home-based interventions in Uganda
including the Apondi et al. study reporting mostly positive social
outcomes of home-based ART among HBAC participants
[33,34], stigma is unlikely to have significantly biased the results
of the socio-behavioral questionnaires; 3) Overall pregnancy
incidence was 8.2 per 100 WY, peaking at 11.7 per 100 WY a
year after ART initiation. By comparison, the 2007 US Census
Bureau age-specific fertility rate for Ugandan women aged 35 to
39 years old was 19.5 births per 100 WY [35]. Thus, both the
overall and peak pregnancy rates following ART initiation in this
study remained well below that of the general population
throughout follow-up; 4) Perhaps the most convincing argument
against a social desirability bias in relation to our findings on the
women’s reported desire for children is the rate of induced
abortions among these women, which was nearly twice that
estimated for Eastern Uganda in 2004 [36]. It is likely than an
even greater number of women attempted but failed to induce
abortions and never disclosed it, as elective abortions are illegal in
Uganda. Moreover, considering the risks and costs these women
faced in attempting abortion, an unknown proportion may have
wanted but never tried to abort. In-depth interviews conducted
with a subset of the women confirm this possibility [37]. Thus, our
data may well underestimate the actual number of women who
wanted and/or attempted to abort; 5) The relatively older age of
the women in our cohort and the fact that over two-thirds of them
already had 3 or more live children at baseline, may also explain
the lack of desire for children among these women. Indeed,
although the factors we found to be associated with pregnancy in
this study mirrored those reported by related studies [38,39]; no
association was found between pregnancy and the number of
children the women had.
After 2 years of follow-up, less than 15% of sexually active
women used any modern method of contraception in addition to,
or apart from condoms, and less than 5% used dual contraception.
These rates were equally low or lower among sexually active
women who did not desire children. In comparison, the Uganda
2006 Demographic Health Survey (DHS) reported a rate of
condom use of 3.2% and a rate of modern contraceptive use of
18% among sexually active women [40] while the Uganda 2004–
05 HIV/AIDS Sero-Behavioral Survey showed that only 7% of
sexually active women used a condom at last sex [41]. Thus,
Sexual behavior Pregnant after ART NOT Pregnant after ART p-value
N=117 % or (IQR) N=591 % or (IQR)
Had sex in past 3 months 48 42% 121 21% ,0.0001
No. of sex partners in last 3 months 0 6 11% 54 31% 0.008
1 47 89% 121 67%
2+ 0 0% 3 2%
Type of current sexual partner Spouse 30 63% 82 68% 0.79
Steady 13 27% 27 22%
Casual 5 10% 12 10%
Partner HIV status *** HIV-negative 24 21% 62 10% 0.30{
HIV-positive 22 19% 81 14%
unknown 71 61% 448 76%
Partner on ART *** 16 14% 52 8.8% 0.10
Ever experienced physical abuse by partner 56 49% 259 44% 0.41
Not worried about transmitting HIV to sexual partner 50 43% 253 44% 0.90
Time since started having sex with recent partner (years) Median (IQR) 4.8 (1.1–13.3) 8.3 (2.5–16.2) 0.11
Sex frequency with current partner [median (IQR)]: in past week 1.0 (1–2) 2.0 (1–2) 0.23
in past month 2.0 (1–3) 2.0 (1–2) 0.14
Always used condom in last 3 months 28 60% 67 57% 0.74
Used condom at last sex 31 65% 72 60% 0.58
*Three women did not have baseline data.
**Among 262 women who answered this question.
***Partners’ HIV or ART status near the time of conception was used for women who became pregnant and by mid-follow-up (or approx. ,12 months) for women who
did not become pregnant, which corresponded to the median time to first incident pregnancy among women who became pregnant.
{excluding unknown.
doi:10.1371/journal.pone.0004149.t001
Table 1. cont.
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although condom use was relatively high among HBAC women,
there was a 4- to 6-fold discrepancy between the women’s own
desire for children and the desire they reported on behalf of their
partners, as well as a significantly higher risk of pregnancy for
women whose male partners did not use condoms consistently. It is
therefore likely that the use of contraceptives in general, and of
condoms in particular in this cohort, may have been highly
dependent on the women’s partners’ approval and cooperation,
which eventually determined the rate of new pregnancies among
these women. Both these assumptions are true in the general and
HIV-infected female populations [40,41,42,43] and were further
emphasized during a 2008 workshop on the impact of HAART on
fertility in sub-Saharan Africa [44]. In addition, many women in
this cohort believed that they or their partner’s were infertile due
to HIV [37], which could have further contributed to their low
contraceptive use other than condoms. These factors are being
further explored through a qualitative study exploring the
perceptions of a subset of these women and their partners about
their desire for children, their pregnancy or lack thereof after
starting ART, and their knowledge, experiences, intentions and
expectations about family planning in relation to ART. These
results contrast with those of a recent cross-sectional survey among
women on ART in another rural area of Uganda that showed
increased use of barrier methods among women on ART [45].
Additional longitudinal studies are warranted to further under-
stand the determinants of contraceptive choice and use among
women and couples on ART.
Finally, a high proportion of women in this study reported
experiencing physical abuse by their partner at baseline. This rate
did not differ from the data on domestic violence reported by the
2006 Uganda Demographic and Health Survey [40], and this
variable was not statistically associated with pregnancy in our
Figure 2. Desire for children and incidence of pregnancy among HBAC women on ART.
doi:10.1371/journal.pone.0004149.g002
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Table 2. Contraceptive use and unmet need for family planning among sexually active women on ART.
Time after start of ART 18 months 24 months
Contraceptive use (N = sexually active women a) 173 b % 188 b %
Not using any contraceptive method c 42 24.3% 59 31.4%
Condom 112 64.7% 119 63.3%
Semi-permanent or permanent method d 24 13.9% 25 13.3%
Dual contraception e 6 3.5% 8 4.3%
Periodic abstinence 7 4.0% 6 3.2%
Unmet need for FP (N = sexually active women a not desiring children) - 176 b %
Not using any contraceptive method c - 59 33.5%
Using condoms only - 93 52.8%
Not using any semi-permanent or permanent method d - 152 86.4%
Not using dual contraceptive method - 168 95.5%
aIn the last 3 months.
bAs respondents could fit in more than one category, percentages add up to more than 100%.
cNot using any semi-permanent or permanent method nor condoms, periodic abstinence or withdrawal.
dIncluding hormonal methods (pills, injections, implants) and tubal ligation (none of the respondents reported the use of intra-uterine devices).
eDefined as the combined use of a barrier and a hormonal method.
doi:10.1371/journal.pone.0004149.t002
Table 3. Cox proportional hazard analysis of baseline and time-dependent factors associated with pregnancy after ART initiation
(N= 117a).
Variable Category or unit Unadjusted HR p-value Adjusted HR p-value
* Age per 10-yr decrease 3.16 (2.30–4.34) ,0.001 2.71 (1.95–3.78) ,0.001
Married / cohabitating (reference = all single parents b) 2.72 (1.88–3.95) ,0.001 1.59 (0.94–2.69) 0.08
Karnofsky score (reference = 0–80) 80–100 1.16 (0.29–4.61) 0.84
Body mass index $18.5 2.50 (1.02–5.88) 0.037 1.09 (1.01–1.18) 0.024
Time-updated CD4 count per 50 cells increase 1.001 (1.000–1.002) 0.045 1.025 (0.98–1.07) 0.26
* Total no of live children 1–2 1.61 (0.50–5.25) 0.43
3+ 1.26 (0.40–4.01) 0.69
* Total no of dead children 1–2 1.35 (0.86–2.12) 0.20
3+ 1.26 (0.74–2.16) 0.40
Wants more children 1.37 (0.55–3.41) 0.50
Planning to have more children 1.01 (0.14–7.30) 0.99
Partner wants more children 1.42 (0.72–2.78) 0.31
Experienced death of a child 1.63 (1.06–2.50) 0.025 1.94 (0.64–5.95) 0.24
Experienced death of spouse 0.19 (0.04–0.88) 0.034 0.49 (0.13–1.83) 0.29
Experienced physical abuse by partner in last 12 months 1.36 (0.91–2.02) 0.13
Worried about transmitting HIV to spouse/partner 1.30 (0.77–2.19) 0.33
Type of sexual partner (reference: spouse) Steady 0.90 (0.51–1.59) 0.71
Casual 0.43 (0.13–1.43) 0.17
Length of sexual relationship with most recent partner per 1 year incr. 0.97 (0.94–0.99) 0.023 0.82 (0.65–1.95) 0.31
Frequency of sex with most recent partner in last month
(reference =#1)
2 0.76 (0.26–2.19) 0.61
.2 1.36 (0.54–3.42) 0.51
Used condom in last 3 months with most recent partner
(reference = always)
Sometimes or never 1.82 (1.05–3.23) 0.033 1.79 (1.02–3.13) 0.041
missing 0.76 (0.71–0.85) 0.005 c 0.61 (0.53–0.70) 0.003 c
*Variables preceded by an asterisk are baseline values; all others are time-dependent variables updated to the time nearest the date of conception.
aThree women without baseline values were excluded from this analysis.
bCombining single, divorced, separated & widowed.
cWomen who reported no sexual activity were not asked about condom use, resulting in a missing value. This significance thus merely reflects the association between
sexual activity and pregnancy. This ‘missing’ category was created to account for the fact that 28 (24%) of 117 women with a first incident pregnancy had a routine
follow-up interview that did not cover the period of conception (i.e. fell outside the 30 to 90 days period following their last menstrual period).
doi:10.1371/journal.pone.0004149.t003
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study. However, given the reported association between domestic
violence and child morbidity and mortality [46], HIV care
programs in Uganda should provide increased support and
protection from physical abuse to their women clients.
Limitations
This study had several limitations: 1) It was not randomized; 2)
Spacing between interviews on sexual behavior varied during follow-
up; 3) Information about contraceptive use was only collected as of 18
months of follow-up, thus it was not possible to assess contraceptive
use as a determinant of pregnancy. However, the low rate of
contraceptive use observed after 18 months of follow-up suggests that
contraceptive use among these women was low throughout follow-up,
as is the case for Ugandan women in general as mentioned above
[40]. This possibility is supported by the results of in-depth interviews
that were conducted after this study was completed with a subset of
both women who did and did not become pregnant after starting
ART [37]; 4) We had no baseline or pre-ART data on the fertility
rate of the women or men in this cohort, nor was a comparison
possible with a matched group of HIV-infected women not on ART.
Therefore we could not assess whether the observed increase in
pregnancy incidence over follow-up was due to an increase in either
fertility or sexual activity among women on ART, or both. However,
the older age of this cohort suggests that ART did have at least a
partial effect on fertility, since pregnancy incidence increased even
though women were older, had a median of 4 children, and thus were
expected to have lower fertility rates and desire for children,
independent of their sexual activity or HIV status. At any rate, the
fact that this increase remained well below the fertility rate of
Ugandan women of the same age may indicate a mere return to
‘normal’ levels of fertility rather than a real increase as compared to
HIV-uninfected women or HIV-infected women not on ART; 5)
Only 27% of all women had a cohabiting partner at the time of their
enrolment into the HBAC program. This rate did not change
substantially around the time of conception nor did it differ
significantly according to the pregnancy outcomes of the women.
Moreover, as partners living outside the women’s household were not
actively traced or tested by the program, the HIV status of the
majority of partners was not known. As well, the type and content of
discussions around fertility and pregnancy that may have taken place
among couples were not assessed in this study. Thus the potential role
of the nature of the couples’ relationships, of the partners’ HIV status
and of the women’s knowledge of it in predicting pregnancy could not
be analyzed in this study. These limitations highlight the need for
more in-depth and controlled research on fertility and reproductive
intentions and outcomes among people on ART. Furthermore, they
underline the importance of incorporating reproductive health
measures into ART study designs, as well as ensuring that ART
programs provide regular counseling for, and continued access to,
reproductive health services including family planning.
The results of this study prompted initiation of an intervention
to increase access to family planning services for both female and
male HBAC study participants. As of July 2006, HBAC counselors
and nurses were retrained in family planning service delivery for
PLHA and started to pro-actively counsel all registered clients on
family planning on a quarterly basis, to deliver hormonal
contraceptives at home, and to actively refer and follow-up
women opting for hormonal implants or tubal ligation to the
hospital family planning clinic.
In conclusion, our results emphasize the need and importance
of making family planning services an integral and continuous part
of ART interventions in Africa. While more research is needed to
further explore the factors that may place women on ART at
increased risk of unwanted pregnancy, women on ART and their
partners should be made clearly aware of the effect of ART on
fertility. All clients on ART should be given full and free access to
family planning services, including dual methods of contraception
[47,48]. Younger women and couples who do not desire children
should be targeted in priority and strongly supported to use
effective contraception to avoid unwanted pregnancies. Pro-active
family planning counseling should be provided not only at the time
of screening patients for ART eligibility but also and more
importantly, on a regular basis thereafter, once patients resume
their normal sexual activity.
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